Acuitas Therapeutics’ Scientists Collaborate with the University of Zurich and the University of Pennsylvania to Develop a Novel Deep Learning Model for Efficient Adenine Base Editing - Life Sciences British Columbia
Summary by lifesciencesbc.ca
1 Articles
1 Articles
Acuitas Therapeutics’ Scientists Collaborate with the University of Zurich and the University of Pennsylvania to Develop a Novel Deep Learning Model for Efficient Adenine Base Editing - Life Sciences British Columbia
Acuitas Therapeutics announced publication “Predicting adenine base editing efficiencies in different cellular contexts by deep learning."
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium